← Leaderboards
Eva Harris
University Of California Berkeley
$40,012,308
Attributed
$52,555,292
Total exposure
28
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $14.5M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$127,340,452 · 30
By mechanism
U19$51,130,212 · 4
P01$34,440,145 · 7
U01$16,103,017 · 3
R01$10,720,482 · 6
D43$6,919,214 · 1
R42$2,657,177 · 1
Top collaborators
- Michele Barry24 shared
- Albert Icksang Ko24 shared
- Purnima Madhivanan24 shared
- Ana Fernandez-Sesma12 shared
- Josefina Coloma6 shared
- Aubree L Gordon4 shared
- Matthew T Aliota2 shared
- Thomas C. Friedrich2 shared
Most similar at University Of California Berkeley
Same institution · by research overlap
- David H Raulet$25,800,180
- Albert Icksang Ko$18,319,672
- Purnima Madhivanan$5,784,882
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionDengueDengue VirusVaccinesImmuneNicaraguaVirus DiseasesSamplingSerotypingAntibodiesResponseVirusProgramsDesignVaccinationCommunitiesImmune ResponseResearch PersonnelCohort StudiesImmunityCollaborationsSeverity Of IllnessViralDengue Infection
Grant awards (138)
Protective immunity following dengue virus natural infections and vaccination$3,121,080
P01 · FY2025 · AI · contact PI
Global Health Emerging Scholars Program$1,071,778
D43 · FY2025 · TW
The paradox of flavivirus antigenic non-reciprocity$1,060,551
R01 · FY2025 · AI
Project 1: Immunological imprinting and immune correlates of antibody and B cell responses in natural dengue virus infections$1,020,372
P01 · FY2025 · AI · contact PI
Living in the post-Zika world: Impact of interactions between dengue and Zika viruses on diagnostics, antibody dynamics, and correlates of disease risk$949,552
U01 · FY2025 · AI · contact PI
Host factors and viral determinants mediating flavivirus NS1 tissue-specific endothelial dysfunction and vascular leak$623,443
R01 · FY2025 · AI · contact PI
Global Health Emerging Scholars Program$515,947
D43 · FY2025 · TW
Global Health Emerging Scholars Program$385,480
D43 · FY2025 · TW
Global Health Emerging Scholars Program$165,490
D43 · FY2025 · TW
Protective immunity following dengue virus natural infections and vaccination$2,527,162
P01 · FY2024 · AI · contact PI
American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES)$1,509,842
U01 · FY2024 · AI · contact PI
The paradox of flavivirus antigenic non-reciprocity$1,085,697
R01 · FY2024 · AI
Living in the post-Zika world: Impact of interactions between dengue and Zika viruses on diagnostics, antibody dynamics, and correlates of disease risk$990,329
U01 · FY2024 · AI · contact PI
Global Health Emerging Scholars Program$976,500
D43 · FY2024 · TW
Host factors and viral determinants mediating flavivirus NS1 tissue-specific endothelial dysfunction and vascular leak$658,551
R01 · FY2024 · AI · contact PI
PROJECT 4: Genetic and Structural Basis for Human Antibody Inhibition of Dengue Viruses$547,436
P01 · FY2024 · AI · contact PI
PROJECT 1: Quality of B Cell and Antibody Responses to Natural Dengue Virus Infections$435,260
P01 · FY2024 · AI · contact PI
The evolution of dengue virus-reactive circulating antibody repertoire$194,832
R21 · FY2024 · AI · contact PI
GHES - NIAID - Tariq$161,823
D43 · FY2024 · TW
GHES - OBSSR - Kimaru$159,373
D43 · FY2024 · TW
Global Health Equity Scholars Program - Melikam$138,841
D43 · FY2024 · TW
GHES - OBSSR - Wild$132,360
D43 · FY2024 · TW
Global Health Emerging Scholars Program$128,030
D43 · FY2024 · TW
GHES - NIEHS - Anafo$87,307
D43 · FY2024 · TW
Global Health Equity Scholars Program - Montenegro-Idrogo$87,307
D43 · FY2024 · TW
GHES - NIAID - Pouye$87,307
D43 · FY2024 · TW
GHES - NIAID - Villasis$87,307
D43 · FY2024 · TW
GHES - OAR - Babirye$87,307
D43 · FY2024 · TW
GHES - NIEHS - Campmier$73,483
D43 · FY2024 · TW
GHES - ORWH - Sudhakar$72,545
D43 · FY2024 · TW
Global Health Equity Scholars Program - Navarro-Galarza$64,178
D43 · FY2024 · TW
GHES - ODP - Katabaro$50,000
D43 · FY2024 · TW
Protective immunity following dengue virus natural infections and vaccination$2,527,162
P01 · FY2023 · AI · contact PI
American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES)$1,546,211
U01 · FY2023 · AI · contact PI
Living in the post-Zika world: Impact of interactions between dengue and Zika viruses on diagnostics, antibody dynamics, and correlates of disease risk$1,002,425
U01 · FY2023 · AI · contact PI
Global Health Emerging Scholars Program$906,500
D43 · FY2023 · TW
Host factors and viral determinants mediating flavivirus NS1 tissue-specific endothelial dysfunction and vascular leak$670,954
R01 · FY2023 · AI · contact PI
PROJECT 1: Quality of B Cell and Antibody Responses to Natural Dengue Virus Infections$436,692
P01 · FY2023 · AI · contact PI
PROJECT 4: Genetic and Structural Basis for Human Antibody Inhibition of Dengue Viruses$369,635
P01 · FY2023 · AI · contact PI
The evolution of dengue virus-reactive circulating antibody repertoire$249,943
R21 · FY2023 · AI · contact PI
Global Health Equity Scholars Program$243,423
D43 · FY2023 · TW
Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.$150,000
D43 · FY2023 · TW
Global Health Equity Scholars Program$126,928
D43 · FY2023 · TW
Protective immunity following dengue virus natural infections and vaccination$2,539,162
P01 · FY2022 · AI · contact PI
American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES)$1,554,254
U01 · FY2022 · AI · contact PI
Living in the post-Zika world: Impact of interactions between dengue and Zika viruses on diagnostics, antibody dynamics, and correlates of disease risk$978,740
U01 · FY2022 · AI · contact PI
Global Health Emerging Scholars Program$960,000
D43 · FY2022 · TW
Host factors and viral determinants mediating flavivirus NS1 tissue-specific endothelial dysfunction and vascular leak$686,252
R01 · FY2022 · AI · contact PI
PROJECT 4: Genetic and Structural Basis for Human Antibody Inhibition of Dengue Viruses$596,582
P01 · FY2022 · AI · contact PI
PROJECT 1: Quality of B Cell and Antibody Responses to Natural Dengue Virus Infections$386,421
P01 · FY2022 · AI · contact PI
Protective immunity following dengue virus natural infections and vaccination$85,631
P01 · FY2022 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$3,000,000
U19 · FY2021 · AI
Protective immunity following dengue virus natural infections and vaccination$2,544,113
P01 · FY2021 · AI · contact PI
American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES)$1,575,273
U01 · FY2021 · AI · contact PI
Living in the post-Zika world: Impact of interactions between dengue and Zika viruses on diagnostics, antibody dynamics, and correlates of disease risk$984,840
U01 · FY2021 · AI · contact PI
PROJECT 1: Quality of B Cell and Antibody Responses to Natural Dengue Virus Infections$442,235
P01 · FY2021 · AI · contact PI
Project 1 - Immune profiling of natural dengue virus infections$299,999
U19 · FY2021 · AI · contact PI
Administrative Supplement to R21: Mechanism and in vivo activity of novel glycan-based therapy against flavivirus endothelial permeability and vascular leak$207,743
R21 · FY2021 · AI · contact PI
Evaluation of in vitro and in vivo efficacy of glycan-based compounds against flavivirus endothelial permeability and vascular leak$200,000
R21 · FY2021 · AI · contact PI
American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES)$175,562
U01 · FY2021 · AI · contact PI
Administrative Supplement for the HEROS Study Serology$152,665
U19 · FY2021 · AI
Protective immunity following dengue virus natural infections and vaccination$85,631
P01 · FY2021 · AI · contact PI
PROJECT 1: Quality of B Cell and Antibody Responses to Natural Dengue Virus Infections$85,631
P01 · FY2021 · AI · contact PI
Mount Sinai IMPACC COVID-19 Cores$5,198,360
U19 · FY2020 · AI
Dengue Human Immunology Project Consortium (DHIPC)$3,000,000
U19 · FY2020 · AI
Protective immunity following dengue virus natural infections and vaccination$2,579,906
P01 · FY2020 · AI · contact PI
American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES)$1,599,082
U01 · FY2020 · AI · contact PI
PROJECT 1: Quality of B Cell and Antibody Responses to Natural Dengue Virus Infections$426,501
P01 · FY2020 · AI · contact PI
Project-003$423,750
U19 · FY2020 · AI
CHARACTERIZATION OF INNATE AND ADAPTIVE IMMUNE RESPONSES INDUCED BY DIFFERENT HUMAN CORONAVIRUSES IN HUMAN PRIMARY SYSTEMS$423,750
U19 · FY2020 · AI
Dissecting novel mechanisms of dengue virus NS1-induced vascular leak$382,705
R01 · FY2020 · AI · contact PI
Administrative Supplement to R21: Mechanism and in vivo activity of novel glycan-based therapy against flavivirus endothelial permeability and vascular leak$241,096
R21 · FY2020 · AI · contact PI
Evaluation of in vitro and in vivo efficacy of glycan-based compounds against flavivirus endothelial permeability and vascular leak$237,500
R21 · FY2020 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$5,858,923
U19 · FY2019 · AI
Protective immunity following dengue virus natural infections and vaccination$2,082,273
P01 · FY2019 · AI · contact PI
Project 1 - Immune profiling of natural dengue virus infections$507,756
U19 · FY2019 · AI · contact PI
Dissecting novel mechanisms of dengue virus NS1-induced vascular leak$382,705
R01 · FY2019 · AI · contact PI
B Cell and Antibody Responses to Natural DENV Infections$305,102
P01 · FY2019 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$7,340,996
U19 · FY2018 · AI
Protective immunity following dengue virus natural infections and vaccination$2,125,099
P01 · FY2018 · AI · contact PI
Project 1 - Immune profiling of natural dengue virus infections$522,569
U19 · FY2018 · AI · contact PI
Dissecting novel mechanisms of dengue virus NS1-induced vascular leak$382,705
R01 · FY2018 · AI · contact PI
B Cell and Antibody Responses to Natural DENV Infections$368,071
P01 · FY2018 · AI · contact PI
Fetal Zika virus infection: role of the human placenta$237,144
R21 · FY2018 · AI
Dengue Human Immunology Project Consortium (DHIPC)$75,220
U19 · FY2018 · AI
B Cell and Antibody Responses to Natural DENV Infections$35,432
P01 · FY2018 · AI · contact PI
Protective immunity following dengue virus natural infections and vaccination$35,432
P01 · FY2018 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$6,860,460
U19 · FY2017 · AI
Protective immunity following dengue virus natural infections and vaccination$2,755,298
P01 · FY2017 · AI · contact PI
Project 1 - Immune profiling of natural dengue virus infections$1,235,755
U19 · FY2017 · AI · contact PI
Dissecting novel mechanisms of dengue virus NS1-induced vascular leak$382,705
R01 · FY2017 · AI · contact PI
B Cell and Antibody Responses to Natural DENV Infections$306,808
P01 · FY2017 · AI · contact PI
Fetal Zika virus infection: role of the human placenta$197,523
R21 · FY2017 · AI
Protective Immunity Following Dengue Virus Natural Infections and Vaccination$102,486
P01 · FY2017 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$7,165,769
U19 · FY2016 · AI
Protective immunity following dengue virus natural infections and vaccination$2,996,634
P01 · FY2016 · AI · contact PI
Project 1 - Immune profiling of natural dengue virus infections$960,378
U19 · FY2016 · AI · contact PI
Dissecting novel mechanisms of dengue virus NS1-induced vascular leak$382,705
R01 · FY2016 · AI · contact PI
B Cell and Antibody Responses to Natural DENV Infections$229,215
P01 · FY2016 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$7,495,258
U19 · FY2015 · AI
Protective immunity following dengue virus natural infections and vaccination$2,106,690
P01 · FY2015 · AI · contact PI
Project 1 - Immune profiling of natural dengue virus infections$608,604
U19 · FY2015 · AI · contact PI
B Cell and Antibody Responses to Natural DENV Infections$234,993
P01 · FY2015 · AI · contact PI
Epidemiology, transmission, and phylogenetics of influenza in a tropical country$595,782
U01 · FY2014 · AI · contact PI
Epidemiology, transmission, and phylogenetics of influenza in a tropical country$702,118
U01 · FY2013 · AI · contact PI
Determinants of protection and enhancement of dengue infection/disease in vivo$350,824
R01 · FY2013 · AI · contact PI
Roles of secreted NS1 and NS1 antibody in dengue virus infection and immunity$273,349
U54 · FY2013 · AI · contact PI
Epidemiology, transmission, and phylogenetics of influenza in a tropical country$639,618
U01 · FY2012 · AI · contact PI
Determinants of protection and enhancement of dengue infection/disease in vivo$373,412
R01 · FY2012 · AI · contact PI
Fitness and Virulence of Dengue Virus in the Context of Changing Host Immunity$296,275
R01 · FY2012 · GM · contact PI
Roles of secreted NS1 and NS1 antibody in dengue virus infection and immunity$272,500
U54 · FY2012 · AI · contact PI
Epidemiology, transmission, and phylogenetics of influenza in a tropical country$644,550
U01 · FY2011 · AI · contact PI
Determinants of protection and enhancement of dengue infection/disease in vivo$366,913
R01 · FY2011 · AI · contact PI
Roles of secreted NS1 and NS1 antibody in dengue virus infection and immunity$306,050
U54 · FY2011 · AI · contact PI
Fitness and Virulence of Dengue Virus in the Context of Changing Host Immunity$296,275
R01 · FY2011 · GM · contact PI
Epidemiology, transmission, and phylogenetics of influenza in a tropical country$654,839
U01 · FY2010 · AI · contact PI
Determinants of protection and enhancement of dengue infection/disease in vivo$377,561
R01 · FY2010 · AI · contact PI
Fitness and Virulence of Dengue Virus in the Context of Changing Host Immunity$295,346
R01 · FY2010 · GM · contact PI
Roles of secreted NS1 and NS1 antibody in dengue virus infection and immunity$295,335
U54 · FY2010 · AI · contact PI
Dengue Reporter Virus Neutralization Assay for Clinical Studies$875,007
R42 · FY2009 · AI · contact PI
Fitness and Virulence of Dengue Virus in the Context of Changing Host Immunity$301,891
R01 · FY2009 · GM · contact PI
Roles of secreted NS1 and NS1 antibody in dengue virus infection and immunity$295,342
U54 · FY2009 · AI · contact PI
Self-contained electromagnetic dengue diagnostic assay$147,207
U54 · FY2009 · AI · contact PI
Dengue Reporter Virus Neutralization Assay for Clinical Studies$867,261
R42 · FY2008 · AI · contact PI
Arboviruses - Cellular Tropism of Dengue Virus in Vivo$250,797
U54 · FY2008 · AI · contact PI
Role of cis & trans factors in dengue virus translation$243,081
R01 · FY2008 · AI · contact PI
Dengue Reporter Virus Neutralization Assay for Clinical Studies$914,909
R42 · FY2007 · AI · contact PI
Role of cis & trans factors in dengue virus translation$292,842
R01 · FY2007 · AI · contact PI
Arboviruses - Cellular Tropism of Dengue Virus in Vivo$243,123
U54 · FY2007 · AI · contact PI
Role of cis & trans factors in dengue virus translation$305,228
R01 · FY2006 · AI · contact PI
Arboviruses - Cellular Tropism of Dengue Virus in Vivo$237,585
U54 · FY2006 · AI · contact PI
Role of cis & trans factors in dengue virus translation$8,054
R01 · FY2006 · AI · contact PI
Dengue Reporter Virus Particle Neutralization Assay$495,686
R41 · FY2005 · AI
Role of cis &trans factors in dengue virus translation$257,791
R01 · FY2005 · AI
Arboviruses - Cellular Tropism of Dengue Virus in Vivo$213,700
U54 · FY2005 · AI
Dengue Reporter Virus Particle Neutralization Assay$500,000
R41 · FY2004 · AI
Role of cis &trans factors in dengue virus translation$256,016
R01 · FY2004 · AI
TAGGING DENGUE VIRUS--A MODEL FOR STUDYING PATHOGENESIS$73,750
R03 · FY2000 · AI